학술논문
Cost-effectiveness analysis of atezolizumab plus bevacizumab compared with sorafenib as first-line treatment in advanced hepatocellular carcinoma in Singapore
Document Type
Article
Author
Source
In: Expert Review of Pharmacoeconomics and Outcomes Research . (Expert Review of Pharmacoeconomics and Outcomes Research, 2024, 24(5):631-641)
Subject
Language
English
ISSN
17448379
14737167
14737167